Targeting microRNA knocks out hepatitis C

Blocking a small molecule, a new drug reduces levels of the virus, chimp study shows

If the Bible’s David were a modern doctor, he might appreciate a new strategy aimed at stopping a Goliath health threat: Bringing down the hepatitis C virus with the help of tiny, precisely targeted molecules.